Antineutrophil cytoplasmic antibodies directed against bactericidal/permeability-increasing protein detected in children with cystic fibrosis inhibit neutrophil-mediated killing of Pseudomonas aeruginosa

Microbes and Infection

Volumn 5, Issue 1, 2003, Pages 27-30

  Šedivá, Anna ^a   Bartůňková, Jiřina ^a   Bartošová, Jana ^a   Jennette, Charles ^b   Falk, Ronald J ^b   Jethwa, Hitendra S ^b  

^a UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Antibodies; Antineutrophil cytoplasmic; Child; Cystic fibrosis; Neutrophils; Pseudomonas aeruginosa

Indexed keywords

BACTERICIDAL PERMEABILITY INCREASING PROTEIN; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY TITER; ARTICLE; BACTERICIDAL ACTIVITY; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; HUMAN; INCUBATION TIME; MALE; NEUTROPHIL; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

ADULT; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIMICROBIAL CATIONIC PEPTIDES; BLOOD PROTEINS; CHILD; CYSTIC FIBROSIS; FEMALE; HUMANS; INFANT; MALE; MEMBRANE PROTEINS; NEUTROPHIL ACTIVATION; NEUTROPHILS; PSEUDOMONAS AERUGINOSA;

PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

EID: 0037276928     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(02)00049-7     Document Type: Article

References (17)

1. Welsh M.J., Tsui L.C., Boat T.F., Beaudet A.L. Cystic fibrosis. Schriver C.R., Baudet A.L., Sly W.S., Valle D. The Metabolic and Molecular Basis of Inherited Diseases. 1995;3799-3879 McGraw Hill, New York.
2. Sediva A., Bartunkova J., Kolarova I., Hrusak O., Vavrova V., Macek Jr M., Lockwood C.M., Dunn A.C. Antineutrophil cytoplasmic autoantibodies (ANCA) in children with cystic fibrosis. J. Autoimmun. 11:1998;185-190.
3. Zhao M.H., Jayne D.R., Ardiles L.G., Culley F., Hodson M.E., Lockwood C.M. Autoantibodies against bactericidal/permeability-increasing protein in patients with cystic fibrosis. Q. J. M. 89:1996;259-265.
4. Falk R.J., Nachman P.H., Hogan S.L., Jennette J.C. ANCA glomerulonephritis and vasculitis: a Chapel Hill perspective. Semin. Nephrol. 20:2000;233-243.
5. Brooks C.J., King W.J., Radford D.J., Adu D., McGrath M., Savage C.O. IL-1 beta production by human polymorphonuclear leucocytes stimulated by anti-neutrophil cytoplasmic autoantibodies: relevance to systemic vasculitis. Clin. Exp. Immunol. 106:1996;273-279.
6. Falk R.J., Terrell R.S., Charles L.A., Jennette J.C. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc. Natl. Acad. Sci. USA. 87:1990;4115-45119.
7. Harper L., Cockwell P., Adu D., Savage C.O. Neutrophil priming and apoptosis in anti-neutrophil cytoplasmic autoantibody-associated vasculitis. Kidney Int. 59:2001;1729-1738.
8. Charles L.A., Caldas M.L., Falk R.J., Terrell R.S., Jennette J.C. Antibodies against granule proteins activate neutrophils in vitro. J. Leukoc. Biol. 50:1991;539-546.
9. Sediva A., Kolarova I., Bartunkova J. Antineutrophil cytoplasmic antibodies in children. Eur. J. Pediatr. 157:1998;987-991.
10. Elsbach P., Weiss J., Levy O. Integration of antimicrobial host defenses: role of the bactericidal/permeability-increasing protein. Trends Microbiol. 2:1994;324-328.
11. Elsbach P., Weiss J. Bactericidal/permeability increasing protein and host defense against Gram-negative bacteria and endotoxin. Curr. Opin. Immunol. 5:1993;103-107.
12. Iovine N.M., Elsbach P., Weiss J. An opsonic function of the neutrophil bactericidal/permeability-increasing protein depends on both its N- and C-terminal domains. Proc. Natl. Acad. Sci. USA. 94:1997;10973-10978.
13. Kobayashi O., Othami S., Marumo T., Arimura J., Kobayashi H., Nagasawa T. Pathogenic role of BPI-ANCA in chronic airway inflammation. Clin. Exp. Immunol. 112:1998;36. (abstract 77).
14. Mahadeva R., Dunn A.C., Westerbeek R.C., Sharples L., Whitehouse D.B., Carroll N.R., Ross-Russell R.I., Webb A.K., Bilton D., Lomas D.A., Lockwood C.M. Anti-neutrophil cytoplasmic antibodies (ANCA) against bactericidal/permeability-increasing protein (BPI) and cystic fibrosis lung disease. Clin. Exp. Immunol. 117:1999;561-567.
15. Cooper T., Savige J., Nassis L., Paspaliaris B., Neeson P., Neil J., Knight K.R., Daskalakis M., Doery J.C. Clinical associations and characterisation of antineutrophil cytoplasmic antibodies directed against bactericidal/permeability-increasing protein and azurocidin. Rheumatol. Int. 19:2000;129-136.
16. Preston G.A., Falk R.J. ANCA signaling: not just a matter of respiratory burst. Kidney Int. 59:2001;1981-1982.
17. Bartunkova J., Araujo A., Hrusak O., Sediva A. Autoimmunity to polymorphonuclears: functional consequences of the binding of antibodies to membrane and cytoplasmic target antigens of polymorphonuclear leukocytes. J. Clin. Immunol. 17:1997;455-461.